Drugs online research references









  • Use of amitriptyline hydrochloride in general practice.
  • Triptanol(amitriptyline hydrochloride) therapy for nocturnal enuresis
  • Noradrenaline, depressive illness, and the action of amitriptyline.
  • Letter: Amitriptyline and imipramine poisoning in children.
  • Letter: Amitriptyline and imipramine poisoning in children.
  • AMITRIPTYLINE AND IMIPRAMINE.
  • Comparative study of imipramine, amitriptyline and their desmethyl analogues in the hypothyroid rat.
  • Repeated treatment with imipramine or amitriptyline increases the locomotor response of rats to (+)-amphetamine given into the nucleus accumbens.
  • Platelet met-enkephalin immunoreactivity and 5-hydroxytryptamine concentrations in migraine patients: effects of 5-hydroxytryptophan, amitriptyline and chlorimipramine treatment.
  • Plasma levels and clinical improvement--a comparative study of clomipramine and amitriptyline in depression.
  • Studies with activated charcoal in the treatment of drug overdosage using the pig as an animal model.
  • Antidepressants do not increase the lethality of ketamine in mice.
  • Carbohydrate craving and increased appetite associated with antidepressant therapy.
  • Reevaluation of the indoleamine hypothesis of depression. Evidence for a reduction of functional activity of central 5-HT systems by antidepressant drugs.
  • The action of imipramine, amitriptyline, doxepin and butriptyline in an operant conditioning schedule.
  • Spinal 5-HT or NA uptake inhibition potentiates supraspinal morphine antinociception in rats.
  • Antidepressant treatments, including sibutramine hydrochloride and electroconvulsive shock, decrease beta 1- but not beta 2-adrenoceptors in rat cortex.
  • Four unusual reactions to amitriptyline.
  • Intraindividual similarity in the metabolism of amitriptyline and chlorimipramine in depressed patients.
  • Cardiac sensitivity to the inhibitory effects of chlorpromazine, imipramine and amitriptyline upon formation of flavins.
  • (+/-)-4-Aryl-4,5-dihydro-3H-1,3-benzodiazepines. 1. Synthesis and evaluation of (+/-)-4,5-dihydro-2,3-dimethyl-4-phenyl-3H-1,3-benzodiazepine and analogues as potential antidepressant agents.
  • Differential effects of chloroquine and of several other amphiphilic cationic drugs upon rat choroid plexus.
  • Comparison of the interaction of tricyclic antidepressants with human polymorphonuclear leukocytes as monitored by the generation of chemiluminescence.
  • Amitriptyline: initial intolerance and subsequent psychosis.
  • Effects of phenelzine and amitriptyline on depression proceedings
  • Cardiovascular effects of amitriptyline in anaesthetized dogs.
  • Construction of ion-selective electrodes for chlorpromazine, amitriptyline, propantheline and meperidine: analytical study and application to pharmaceutical analysis.
  • Amitriptyline and EEG sleep in depressed patients: I. Drug effect.
  • Psychoactive medication use in intermediate-care facility residents.
  • Effects of serotonin on the internal anal sphincter: in vivo manometric study in rats.
  • Evaluation of amitriptyline in migraine prophylaxis.
  • Poisoning by amitriptyline, imipramine and nortriptyline.
  • EFFECT OF AMITRIPTYLINE ON ADRENAL CORTEX IN STRESS.
  • Metabolism of amitriptyline in patients with chronic renal failure.
  • Nortriptyline and EEG sleep in depressed patients.
  • A comparison in rabbit isolated hearts of the dysrhythmogenic potential of amitriptyline, maprotiline and mianserin in relation to their ability to block noradrenaline uptake.
  • The inhibiting effect of amitriptyline, bamipin and chlorprothixene on the content of adrenaline and noradrenaline in the adrenal vein of dogs and their adrenomedullary secretion caused by acetylcholine.
  • Urinary 4-hydroxy-3-methoxyphenylglycol is not a predictor for clinical response to amitriptyline in depressive illness.
  • Dorsal root entry zone lesions for the treatment of post-herpetic neuralgia.
  • Failure of urinary MHPG levels to predict treatment response in patients with unipolar depression.
  • Controlled comparison of amitriptyline and meperidine as preanesthetic treatment.
  • Quantitative liquid-chromatographic technique for the simultaneous assay of tricyclic antidepressant drugs in plasma or serum.
  • Jaundice associated with amitriptyline.
  • Thin layer sorbent chromatography of amitriptyline and nortriptyline
  • Long-acting amitriptyline (lentizol) in the treatment of depression
  • Behavioral predictors of amitriptyline response in depression.
  • Liquid chromatography of amitriptyline and related tricyclic compounds.
  • Studies of blocking mechanisms of carbachol-induced polyphosphoinositide turnover in rat cortical synaptosomes by neuroactive drugs.
  • Analgesic properties of meperidine, amitriptyline and phenelzine in mice.
  • Amitriptyline and its metabolites: blood and urine levels in overdose.
  • TOXICITY STUDIES WITH AMITRIPTYLINE. THERAPEUTIC GUIDE LINES FROM EXPERIMENTAL STUDIES
  • Acute response to methylphenidate as a predictor of outcome of treatment with TCAs in the elderly.
  • Cerebrospinal fluid amine metabolites after combined amitriptyline-triiodothyronine treatment of depressed women.
  • Urinary metabolites of amitriptyline in the dog.
  • A sensitive gas chromatographic assay for amitriptyline and nortriptyline in plasma.
  • The role of plasma level monitoring of tricyclic antidepressant drugs as an aid to treatment.
  • Evaluation of the EMIT amitriptyline and nortriptyline assays for the determination of serum clomipramine and desmethylclomipramine.
  • Pharmacological profile of moclobemide, a short-acting and reversible inhibitor of monoamine oxidase type A.
  • Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system.
  • Chronic treatment with amitriptyline produces subsensitivity to the hypothermic effects of clonidine.
  • Carbamazepine metabolism in man. Induction and pharmacogenetic aspects.
  • Behavioral pharmacology of mianserin hydrochloride, a new antidepressant
  • Three cases of action myoclonus during treatment with imipramine and amitriptyline
  • A radioreceptor assay for neuroleptic drugs in plasma.
  • Recent concepts of neuromodulators in affective disorders.
  • High-performance liquid chromatographic quantitation of amitriptyline and nortriptyline in dialysate from plasma or serum using on-line solid-phase extraction.
  • Pre-treatment neurotransmitter metabolites and response to imipramine or amitriptyline treatment.
  • Amitriptyline (Elavil), a new antidepressant.
  • Cardiological effects of nomifensine, a new antidepressant.
  • Interactions of a non-selective monoamine oxidase inhibitor, phenelzine, with inhibitors of 5-hydroxytryptamine, dopamine or noradrenaline re-uptake.
  • Cytogenetic effects of amitriptyline hydrochloride in somatic and germ cells of mice.
  • A comparison of nortriptyline and amitriptyline in depression.
  • Correlation of initial amitriptyline concentration reduction with activated charcoal therapy in overdose patients.
  • Alternative therapy with noxiptilin and amitriptyline in clinical-stationary treated depression
  • Classical and non-classical neuroleptics induce supersensitivity of nigral GABA-ergic mechanisms in the rat.
  • Action of imipramine, amitriptyline and cocaine on auto-stimulation in the rat
  • Differential effect of chronic desipramine and amitriptyline treatment on rat brain adrenergic and serotonergic receptors.
  • Lithium in the prevention of affective disorders: 20 years' experience
  • Comparison of some effects of paroxetine with amitriptyline on the cardiovascular system in animals.
  • Effect of prolonged 5-hydroxytryptamine uptake inhibition by paroxetine on cortical beta 1 and beta 2-adrenoceptors in rat brain.
  • Evaluation and management of resistant depressions with an amitriptyline-isocarboxazid combination
  • Quantitative determination of amitriptyline in blood.
  • Incidence and potentiation of external and internal fetal anomalies resulting from chlordiazepoxide and amitriptyline alone and in combination.
  • Simultaneous determination of amitriptyline, nortriptyline and their respective isomeric 10-hydroxy metabolites in plasma by liquid chromatography.
  • Quantitative determination of amitriptyline and nortriptyline in plasma by high-performance liquid chromatography.
  • Effect of imipramine, amitriptyline and their monomethyl derivatives on reserpine activity.
  • Effects of antidepressants on receptor-activated and Ca2+-activated contractions of rabbit isolated aorta.
  • Trial of amitriptyline in chronic depression.
  • POLYGRAPHIC STUDY OF AMITRIPTYLINE. (SIMULTANEOUS RECORDING OF THE ELECTROENCEPHALOGRAM, RESPIRATION, HEART RATE AND ARTERIAL PRESSURE)
  • Effects of antidepressants on the uptake and release of norepinephrine from rat cerebral cortex.
  • Clinical trials with amitriptyline with special attention to the possible occurrence of toxic action on blood count and liver function
  • Non-differential inhibition of histamine and serotonin release from mast cells by amitriptyline.
  • The inhibition of monoamine oxidase by tricyclic antidepressants: the influence of the nature of the substrate and the source of the enzyme.
  • The effect of amitriptyline on the central nervous system penetration of methotrexate.
  • Psychophysiological aspects of depressive syndromes.
  • The effect of amitriptyline on the behaviour and EEG of rats after depletion of serotonine by parachlorphenylamine.
  • Study in psychodermatology of 2 associations with mixed action, antidepressive and tranquilizing (amitriptyline + perphenazine)
  • Quantitative determination of tricyclic antidepressant drugs by high-pressure liquid chromatography
  • Role of the central adrenergic system in mediating amitriptyline-induced alteration in the mammalian blood-brain barrier in vivo.
  • Sedative/anxiolytic effects of antidepressants in animals.
  • The effect of amitriptyline on presynaptic mechanisms in noradrenergic nerves.
  • Myocardial pharmacokinetics of amitriptyline and clomipramine in the isolated, perfused rabbit heart.
  • Help-seeking in depressed out-patients following maintenance therapy.
  • Inhibition of sparteine oxidation in human liver by tricyclic antidepressants and other drugs.
  • Experiences from a facial pain unit.
  • Cardiovascular effects of paroxetine, a newly developed antidepressant, in anesthetized dogs in comparison with those of imipramine, amitriptyline and clomipramine.
  • CLINICAL TRIALS WITH AMITRIPTYLINE AND PERPHENAZINE AMONG PSYCHIATRIC OUTPATIENTS.
  • COMBINED AMITRIPTYLINE AND PERPHENAZINE IN COMBINED DEPRESSION AND ANXIETY.
  • Biotransformation of amitriptyline in man: interaction with phenothiazines.
  • AMITRIPTYLINE POISONING. CLINICAL AND PATHOLOGICAL FINDINGS IN A FATAL CASE.
  • Effects of systemically administered monoamine reuptake blocking agents on patterns of buspirone-induced analgesia in rats.
  • Amitriptyline and perphenazine (Triptafen DA) in chronic pain.
  • Individual conditions of pharmacogenic confusion conditions. Comparison of amitriptyline and clozapine
  • Single oral dose pharmacokinetics of amitriptylinoxide and amitriptyline in humans.
  • Amitriptyline pharmacokinetics. Lentizol and ordinary amitriptyline tablets compared in a cross-over study of steady state plasma drug levels in depressed patients.
  • On the peripheral pharmacology of amitriptyline.
  • Comments on the British Pharmacopoeia 1973 assay of amitriptyline injection.
  • Combined amitriptyline and phenelzine poisoning.
  • Acute psychosis with amitriptyline and furazolidone.
  • Immediate effects of physostigmine on amitryptyline-induced QRS prolongation.
  • Amitriptyline overdosage: plasma concentrations and clinical features proceedings
  • Radioimmunoassay of clomipramine and amitriptyline. Monitoring plasma levels of clomipramine in endogenous depression
  • The 24-hour profile of plasma prolactin in men with major endogenous depressive illness.
  • Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients.
  • The demethylation of amitriptyline administered by oral and intramuscular routes.
  • Tricyclic antidepressants: plasma levels and clinical findings in overdose.
  • Limbitrol (amitriptyline plus chlordiazepoxide) revisited.
  • Alterations of tubulin function caused by chronic antidepressant treatment in rat brain.
  • The novel analgesic compound OT-7100 (5-n-butyl-7-(3,4,5-trimethoxybenzoylamino)pyrazolo1,5-apyrimid ine) attenuates mechanical nociceptive responses in animal models of acute and peripheral neuropathic hyperalgesia.
  • A Markov process analysis comparing the cost effectiveness of maintenance therapy with citalopram versus standard therapy in major depression.
  • Amitriptyline and procainamide inhibition of cocaine and cocaethylene degradation in human serum in vitro.
  • Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat.
  • Depression after minor closed head injury: role of dexamethasone suppression test and antidepressants.
  • Chronopharmacokinetics of amitriptyline in rats.
  • Effect of some psychotropic drugs on the activated macrophage-induced luminol-dependent chemiluminescence.
  • Effect of potassium channel modulators in mouse forced swimming test.
  • Determination of norepinephrine in microdialysis samples by microbore column liquid chromatography with fluorescence detection following derivatization with benzylamine.
  • Acute amitriptyline in a rat model of neuropathic pain: differential symptom and route effects.
  • Determination of amitriptyline and nortriptyline in human liver microsomes with reversed-phase HPLC in vitro.
  • Regulation of glucocorticoid receptor-mRNA in human blood cells by amitriptyline and dexamethasone.
  • Serotonin receptor subtype gene expression in the hippocampus of aged rats following chronic amitriptyline treatment.
  • The relationship between pupil diameter and pain by the administration of morphine and antidepressant drugs in mice.
  • Amitriptyline absorption in a patient with short bowel syndrome.
  • Applications of column-switching technique in biopharmaceutical analysis. I. High-performance liquid chromatographic determination of amitriptyline and its metabolites in human plasma.
  • Heterogeneity of 5-hydroxytryptamine receptors in the rat uterus and stomach strip.
  • Longitudinal patterns of antidepressant prescribing in primary care in the UK: comparison with treatment guidelines.
  • Inhibition of the high affinity myo-inositol transport system: a common mechanism of action of antibipolar drugs?
  • Inhibition of the current of heterologously expressed HERG potassium channels by imipramine and amitriptyline.
  • Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurones.
  • Interaction of amitriptyline and low doses of physostigmine studied by method of food motor reflexes in cats.
  • Ileus after amitriptyline.
  • Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures.
  • Lysosomal trapping as an important mechanism involved in the cellular distribution of perazine and in pharmacokinetic interaction with antidepressants.
  • Amitriptyline increases GABA-stimulated 36Cl- influx by recombinant (alpha 1 gamma 2) GABAA receptors.
  • SEVERE TOXIC REACTION TO COMBINED AMITRIPTYLINE AND THIORIDAZINE.
  • The inhibition of GLUT1 glucose transport and cytochalasin B binding activity by tricyclic antidepressants.
  • Block of human heart hH1 sodium channels by amitriptyline.
  • Suicide by antidepressant intoxication identified at autopsy in Vienna from 1991-1997: the favourable consequences of the increasing use of SSRIs.
  • Effects of antidepressants in adrenergic neurotransmission of human vas deferens.
  • Idiopathic Subjective Tinnitus Treated by Amitriptyline Hydrochloride/Biofeedback.
  • Nonspecific binding of drugs to human liver microsomes.
  • Amitriptyline-induced constipation in cynomolgus monkeys is beneficial for the evaluation of laxative efficacy.
  • Reflex sympathetic dystrophy: alternative modalities for pain management.
  • Acute administration of amitriptyline and mianserin increases dopamine release in the rat nucleus accumbens: possible involvement of serotonin2C receptors.
  • Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: A longitudinal study in patients treated with amitriptyline or paroxetine.
  • Treatment of depression. Comparative study on the effects of mianserin (Tolvin) and amitriptyline
  • Vulvodynia: a dermatologist's perspective with emphasis on an irritant contact dermatitis component.
  • Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments.
  • Antidepressant drugs inhibit glucocorticoid receptor-mediated gene transcription - a possible mechanism.
  • In vitro studies of the phototoxic potential of the antidepressant drugs amitriptyline and imipramine.
  • The effects of amitriptyline, mianserin, phenoxybenzamine and propranolol on the release of noradrealine in the rat brain in vivo.
  • Antioxidant defense against antidepressants in C6 and 1321N1 cells.
  • Modulation of halofantrine resistance after coadministration of halofantrine with diverse pharmacological agents in a rodent malaria model.
  • The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice.
  • Amitriptyline
  • Economic impact of using mirtazapine compared to amitriptyline and fluoxetine in the treatment of moderate and severe depression in the UK.
  • Steady-state plasma concentrations of cis- and trans-10-OH amitriptyline metabolites.
  • Comparison of three in vitro assays at evaluation of IC50 of acetylsalicylic acid, ferrous sulfate, amitriptyline, methanol, isopropanol and ethylene glycol in human cancer cells HeLa.
  • Effect of dopaminergic drugs on the reserpine-induced lowering of hippocampal theta wave frequency in rats.
  • Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis.
  • Studies on accumulation of (14C)-mescaline in brain homogenates: effects of psychotropic and other agents.
  • Diabetic Neuropathies.
  • Treatments used in women with interstitial cystitis: the interstitial cystitis data base (ICDB) study experience. The Interstitial Cystitis Data Base Study Group.
  • Differential effects of tricyclic antidepressant drugs on membrane dynamics--a fluorescence spectroscopic study.
  • The xenobiotic inhibitor profile of cytochrome P4502C8.
  • Differential effects of short-and long-term antidepressant treatments on the food-induced place preference conditioning in rats.
  • Effect of amitriptyline on daily variations in cell composition of immune organs in rats with experimental desynchronosis.
  • Relationship between 3H-histamine uptake and H2-receptors in the human promyelocytic leukemia cell line HL-60.
  • Weight outcomes among antidepressant users in nursing facilities.
  • Dopaminergic activity in transgenic mice underexpressing glucocorticoid receptors: effect of antidepressants.
  • Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate.
  • Costs and outcomes of use of amitriptyline, citalopram and fluoxetine in major depression: exploratory study.
  • In vitro reaction of formaldehyde with fenfluramine: conversion to N-methyl fenfluramine.
  • Inhibition of synovial plasma extravasation by preemptive administration of an antiinflammatory irrigation solution in the rat knee.
  • Effects of some centrally active drugs on the allopregnanolone synthesis in rat brain.
  • Ring flexibility within tricyclic antidepressant drugs.
  • Lack of central 5-hydroxytryptamine influence on the anticonflict activity of diazepam.
  • Amitriptyline versus bupivacaine in rat sciatic nerve blockade.
  • MHPG, amitriptyline and affective disorders. A longitudinal study.
  • Determination of amitriptyline and cocaine by GC and GC/MS in biological fluids.
  • Retro-orbital tumour--an uncommon cause of headache in pregnancy.
  • Assessment of DNA damage in C6 glioma cells after antidepressant treatment using an alkaline comet assay.
  • A systematic screening and identification method for 29 central nervous system drugs in body fluid by high performance capillary electrophoresis
  • Interaction of psychotropic drugs with monoamine oxidase in rat brain.
  • Comparison of efficacy of ginger with various antimotion sickness drugs.
  • Determination of therapeutic levels of amitriptyline in serum by chromatography.
  • Determination of amitriptyline and its major basic metabolites in human urine by high-performance liquid chromatography.
  • Effect of amitriptyline and nortriptyline on the intracular pressure and aqueous humor dynamics in rabbits
  • Plasma levels of amitriptyline: effect of age and sex.
  • Discriminative stimulus control with imipramine: transfer to other anti-depressants.
  • Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions.
  • A gas chromatographic method for the determination of amitriptyline and nortriptyline in human serum.
  • Development of a novel probe for measuring drug binding to the F1*S variant of human alpha 1-acid glycoprotein.
  • A study of mechanisms underlying amitriptyline-induced acute lung function impairment.
  • Family physicians' use of medical abstracts to guide decision making: style or substance?
  • Clomipramine and amitriptyline in depressed outpatients. A controlled study.
  • Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort ( Hypericum perforatum ).
  • Determination of amitriptyline in plasma samples by high-performance liquid chromatography.
  • N-Glucuronidation of some 4-arylalkyl-1H-imidazoles by rat, dog, and human liver microsomes.
  • Amitriptyline and clomipramine activate Gi-protein signaling pathway in the induction of analgesia.
  • Theoretical and practical considerations on the acute effects of intravenous injection of amitriptyline
  • Diabetic neuropathic cachexia. Beneficial response to combination therapy with amitriptyline and fluphenazine.
  • Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.
  • Rx drugs
  • The interaction between gabapentin and amitriptyline in the rat formalin test after systemic administration.
  • ECT-Induced Myoclonus.
  • Experiences with amitriptyline in elderly patients.
  • Evolution of visceral sensitivity in patients with irritable bowel syndrome.
  • Antidepressants inhibit human acetylcholinesterase and butyrylcholinesterase activity.
  • Amitriptyline changes the pharmacokinetic profile of histamine in rat blood.
  • In vitro cytotoxicity testing with fluorescence-based assays in cultured human lung and dermal cells.
  • Facial pain following sinonasal surgery or facial trauma.
  • Characteristics of the cortical and hippocampal EEG power spectra of rabbits during normal behavioral states and after administration of CNS acting drugs.
  • Determination of amitriptyline and nortriptyline in human plasma by quantitative thin-layer chromatography.
  • The effect of the nitric oxide synthesis inhibitor L-NAME on amitriptyline-induced hypotension in rats.
  • Uptake of 5-hydroxytryptamine by blood platelets incubated in plasma from rats and humans treated with amitriptyline and imipramine.
  • Platelet MAO and amitriptyline treatment.
  • N-phenylethyl amitriptyline in rat sciatic nerve blockade.
  • The impact of CYP2C19 and CYP2D6 genotypes on metabolism of amitriptyline in Japanese psychiatric patients.
  • Gabapentin: new indication. In postherpetic neuralgia when amitriptyline fails.
  • Adverse pulmonary vascular effects of high dose tricyclic antidepressants: acute and chronic animal studies.
  • Inactivation of Gi proteins induces an antidepressant-like effect in the mouse forced-swimming test.
  • Simultaneous dissolution profiles of two drugs, sulfadiazine-trimethoprim and amitriptyline-perphenazine, in solid oral dosage forms by a FIA manifold provided with a single spectrophotometric detector.
  • Chemical toxicology for the coroner.
  • EXPERIMENTS WITH AMITRIPTYLINE IN ALCOHOLISM
  • The isolation of amitriptyline from cadaveric material using acetonitrile
  • The prescribing of psychotropic drugs in mental health services in Trinidad.
  • Determination of amitriptyline hydrochloride by zero-current oscillo-potentiometric and bipotentiometric methods
  • Clinical features and outcome in dogs and cats with obsessive-compulsive disorder: 126 cases (1989-2000).
  • Inhibition and possible induction of rat CYP2D after short- and long-term treatment with antidepressants.
  • Tricyclic analogs cyclobenzaprine, amitriptyline and cyproheptadine inhibit the spinal reflex transmission through 5-HT(2) receptors.
  • Cardiotoxicity of amitriptyline.
  • Effect of amitriptyline on gastric ulceration.
  • Cardiotoxicity of amitriptyline.
  • Despite various drugs, cats continue to kill mice.
  • Comparative efficacy and tolerance of fluvoxamine and amitriptyline in the treatment of moderate and severe depression in mental hospital
  • Peripheral interactions between dextromethorphan, ketamine and amitriptyline on formalin-evoked behaviors and paw edema in rats.
  • Sustained release amitriptyline (lentizol) in depressive illness.
  • Acute delirium in amitriptyline-perphenazine therapy of alcoholism.
  • Determination of amitriptyline and metabolites in various organs after fatal poisoning
  • Tricyclic antidepressants as long-acting local anesthetics.
  • Cutaneous analgesia after transdermal application of amitriptyline versus lidocaine in rats.
  • Gas-chromatographic analysis for therapeutic concentrations of amitriptyline and nortriptyline in plasma, with use of a nitrogen detector.
  • Selective decrease in serotonin synthesis rate in rat brainstem raphe nuclei following chronic administration of low doses of amitriptyline: an effect compatible with an anti-migraine effect.
  • Prevention of postherpetic neuralgia: does it exist?
  • High-performance thin-layer chromatographic determination of psychopharmacologic agents in blood serum.
  • Antidepressants: psychiatrists' opinions and clinical practice.
  • The relative toxicity of amitriptyline, bupivacaine, and levobupivacaine administered as rapid infusions in rats.
  • Identification of dopamine transporter in bovine pineal gland using 3HGBR 12935.
  • Dynamic changes in AP-1 transcription factor DNA binding activity in rat brain following administration of antidepressant amitriptyline and brain-derived neurotrophic factor.
  • Effect of antidepressants on the phospholipase A2 activity in plasma membranes of the rat brain cortex.
  • Spectrum of psychotropic effects and mechanism of action of ultra low doses of the antibodies to S-100 protein (proproten)
  • Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring.
  • Adverse effects of antidepressive agents in hospitalized geriatric patients
  • Effects of some antidepressant drugs on tryptaminergic responses of the rat jejunum.
  • A fatal case of hyperthermia due to tricyclic antidepressant intoxication.
  • New mechanism of plasmid curing by psychotropic drugs.
  • Antidepressant properties of proproten and amitriptyline: comparative experimental study.
  • Antinociceptive effects of tricyclic antidepressants and their noradrenergic metabolites.
  • Salivation test in patients with affective disorders treated with amitriptyline, mianserin and electroconvulsive therapy
  • Weight gain during antidepressant therapy
  • In vitro studies of the efficacy of reversed phase silica gel as a sorbent for hemo- and plasmaperfusion.
  • Antidepressants increase glucocorticoid and mineralocorticoid receptor mRNA expression in rat hippocampus in vivo.
  • Evaluation of central adrenergic receptor signal transmissions after an antidepressant administration to the rat.
  • Selective 5-HT1A and 5-HT2 receptor-mediated adrenocorticotropin release in the rat: effect of repeated antidepressant treatments.
  • A comparison of various antidepressant drugs demonstrates rapid desensitisation of alpha 2-adrenoceptors exclusively by sibutramine hydrochloride.
  • Determination of amitriptyline in the hair of psychiatric patients.
  • Amitriptyline: reappraisal after six years experience.
  • Clinical course, therapy, outcome and analytical data in amitriptyline and combined amitriptyline/chlordiazepoxide overdose.
  • Prescription of psychopharmaca in common psychiatric diagnoses (discussion on the results of an anonymous survey).
  • On the use of Amitriptyline in psychiatry
  • The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.
  • The discriminative stimulus effects of clozapine in pigeons: involvement of 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
  • Non-selectivity of amitriptyline for subtypes of brain muscarinic receptors demonstrated in binding and functional assays.
  • The effect of antidepressant drugs on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist.
  • Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors.
  • AMITRIPTYLINE OR LAROXYL IN DEPRESSIVE SYNDROMES
  • Epileptic fits and amitriptyline.
  • Chronic amitriptyline decreases autotomy following dorsal rhizotomy in rats.
  • EFFECTS OF AMITRIPTYLINE ON DEPRESSIVE STATES
  • Epileptic fits and amitriptyline.
  • In vitro forecasting of drugs that may interfere with codeine bioactivation.
  • Psychoactive drugs and the risk of injurious motor vehicle crashes in elderly drivers.
  • Effects of antidepressants on G protein-coupled receptor signaling and viability in Xenopus laevis oocytes.
  • Sympathetic blockade and amitriptyline in the treatment of reflex sympathetic dystrophy.
  • Liver delta-aminolevulinate dehydratase activity in amitriptyline- or chlorpromazine-treated rats.
  • Efficacy and safety of venlafaxine ER vs. amitriptyline ER in patients with major depression of moderate severity.
  • Drugs for preventing migraine headaches in children.
  • Hepatitis caused by amitriptyline therapy.
  • In vivo spectrophotometric determination of striatal acetylcholinesterase activity: the modulation induced by the antidepressant amitriptyline.
  • Catanionic drug-surfactant mixtures: phase behavior and sustained release from gels.
  • Effects of cytochrome b(5) on drug oxidation activities of human cytochrome P450 (CYP) 3As: similarity of CYP3A5 with CYP3A4 but not CYP3A7.
  • Solubilization of cationic drugs in lung surfactant.
  • A CLINICAL TRIAL OF AMITRIPTYLINE IN DEPRESSIVE PATIENTS.
  • Primary position upbeat nystagmus associated with amitriptyline use.
  • Treatment and care of neurotoxicity from taxane anticancer agents.
  • Regulation of the Human Corticotropin-Releasing-Hormone Gene Promoter Activity by Antidepressant Drugs in Neuro-2A and AtT-20 Cells.
  • A novel system for the determination of antidepressant concentrations in human breast milk.
  • Urine sample preparation of tricyclic antidepressants by means of a supported liquid membrane technique for high-performance liquid chromatographic analysis.
  • Influence of the light schedule on the toxicity of amitriptyline in chick embryos.
  • A sensitive method for the determination of amitriptyline and nortriptyline in human plasma.
  • Serum concentrations of amitriptyline and its metabolites and clinical effect in depressive patients
  • Predictors of outcome in the treatment of chronic "psychogenic" pain with amitriptyline and brief psychotherapy.
  • Trial of amitriptyline for relief of pain in amputees: results of a randomized controlled study.
  • Amitriptyline attenuates the febrile response to a pyrogen in rabbits.
  • Interaction of tricyclic antidepressants with cholestyramine in vitro.
  • Comparative study of two techniques for the determination of amitriptyline and nortriptyline: EMIT and gas chromatography
  • Debrisoquine hydroxylation phenotypes of patients with high versus low to normal serum antidepressant concentrations.
  • EEG activation with amitriptyline.
  • Interaction between amitriptyline and phenothiazine in man: effect on plasma concentration of amitriptyline and its metabolite nortriptyline and the correlation with clinical response.
  • Amitriptyline and amitriptyline metabolites in blood and cerebrospinal fluid following human overdose.
  • Response of postpsychotic depression to adjunctive imipramine or amitriptyline.
  • The effects of long-term administration of antidepressant drugs on intracranial self-stimulation responding in rats.
  • Analysis of 20 cases of amitriptyline poisoning
  • Inhibition and metabolite complexation of rat hepatic microsomal cytochrome P450 by tricyclic antidepressants.
  • Fluoxetine-induced inhibition of synaptosomal 3H5-HT release: possible Ca(2+)-channel inhibition.
  • Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses.
  • Amitriptyline prevents N-methyl-D-aspartate (NMDA)-induced toxicity, does not prevent NMDA-induced elevations of extracellular glutamate, but augments kainate-induced elevations of glutamate.
  • Blockade of cardiac sodium channels by amitriptyline and diphenylhydantoin. Evidence for two use-dependent binding sites.
  • Amitriptyline-mediated inhibition of neurite outgrowth from chick embryonic cerebral explants involves a reduction in adenylate cyclase activity.
  • Chronic treatment with amitriptyline alters the GABA-mediated uptake of 36Cl- in the rat brain.
  • The potentiation by amitriptyline of liver changes induced by ethanol in mice.
  • Anacollagenase by the action of amitriptyline on Clostridium histolyticum collagenase
  • Amitriptyline in severely depressed spinal cord-injured patients: rapidity of response.
  • Radioimmunoassay of amitriptyline and nortriptyline in body fluids.
  • MIF-1 potentiates the action of tricyclic antidepressants in an animal model of depression.
  • Comparative effects of antidepressants, amitriptyline, and maprotiline on intraventricular conduction, effective refractory period, and incidence of ventricular arrhythmias induced by programmed stimulation in dog hearts after myocardial infarction.
  • Effects of a secondary and a tertiary amine tricyclic antidepressant on cerebral biogenic amines as a function of mouse strain: a comparative neurotoxicological evaluation.
  • A three-dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation.
  • Imipramine as a discriminative stimulus.
  • Therapeutic use of amitriptyline in irritable colon
  • Relationship of dose to antidepressant prophylactic efficacy.
  • Studies on antidepressant effects of several overshort peptides (OSP)
  • An experimental study of the antidepressive properties of captopril
  • Tricyclic antidepressant agents. II. Effect of oral administration on the uptake of 3-H-noradrenaline and 14-C-5-hydroxytryptamine in slices of the midbrain-hypothalamus region of the rat.
  • Early individualization of tricyclic antidepressant dosing using a Bayesian pharmacokinetic model.
  • A study of low-dose amitriptyline overdoses.
  • Levels of amitriptyline and its metabolites in the treatment of depression
  • Pharmacokinetics of amitriptyline infused intravenously in man.
  • Stereoselective efflux of (E)-10-hydroxynortriptyline enantiomers from the cerebrospinal fluid of depressed patients.
  • The use of different physicochemical analysis methods for proving combined poisoning by aminazine, tizertsin and amitriptyline
  • Interaction of mianserin, amitriptyline and haloperidol with guinea pig cerebral histamine H2 receptors studied with 125Iiodoaminopotentidine.
  • Chronic electroconvulsive treatment augments coupling of the GTP-binding protein Gs to the catalytic moiety of adenylyl cyclase in a manner similar to that seen with chronic antidepressant drugs.
  • Determination of plasma amitriptyline by electron-capture gas chromatography after oxidation to anthraquinone.
  • Hepatocellular peroxisomes in human alcoholic and drug-induced hepatitis: a quantitative study.
  • Chlordiazepoxide in depressive neurosis: an open label cross-over study with amitriptyline.
  • Tricyclic drugs reduce proton motive force in Leishmania donovani promastigotes.
  • Reduction in beta-adrenoceptor density in cultured rat glioma C6 cells after incubation with antidepressants is dependent upon the culturing conditions used.
  • HUMAN METABOLIZATION OF AMITRIPTYLINE TAGGED WITH CARBON-14.
  • A comparison of three computer models for prediction of dose in acute amitriptyline overdose.
  • Repeated treatment with amitriptyline reduces immobility in the behavioural 'despair' test in rats by activating dopaminergic and beta-adrenergic mechanisms.
  • Rapid and simple high-performance liquid chromatographic determination of tricyclic antidepressants for routine and emergency serum analysis.
  • Circadian rhythmicity in the stimulation of bioluminescence by biogenic amines and MAO inhibitors in Gonyaulax polyedra.
  • Studies on the effects of antidepressant drugs on the antinociceptive action of morphine and on plasma morphine in rat and man.
  • The influence of ethanol on the distribution of amitriptyline and nortriptyline in rats.
  • 5-HT uptake inhibitors and tricyclic antidepressants: relation between tryptophan availability and clinical response in depressed patients.
  • A central nervous system depressant-antidepressant.
  • Repeated treatment with imipramine, amitriptyline or electroconvulsive shock does not affect the 8-OH-DPAT-induced increase in food intake in free feeding rats.
  • Repeated treatment with amitriptyline or electroconvulsive shock does not affect thyrotropin releasing hormone receptors in discrete rat brain structures.
  • A drug utilization review of prescribing patterns for trazodone versus amitriptyline.
  • The effect of antidepressants on the experimental anticonvulsant activity and acute toxicity of anticonvulsants
  • Myotonic dystrophy: quantification of muscle weakness and myotonia and the effect of amitriptyline and exercise.
  • The electrocardiogram as a tool for therapeutic monitoring: a critical analysis.
  • An automated analysis of REM sleep in primary depression.
  • REM-suppressing effects of amitriptyline and amitriptyline-N-oxide after acute medication in healthy volunteers: results of two uncontrolled pilot trials.
  • Aspects of amitriptyline and nortriptyline plasma levels monitoring in depression.
  • The interaction of amitriptyline, doxepin, imipramine and their N-methyl quaternary ammonium derivatives with subtypes of muscarinic receptors in brain and heart.
  • Determination of serum desipramine and 2-hydroxydesipramine for pharmacokinetic applications by HPLC with ultraviolet detection.
  • Inhibitory effects of amitriptyline on the stimulation-induced Ca2+ increase in parotid acini.
  • Formation of cytotoxic metabolites from phenytoin, imipramine, desipramine, amitriptyline and mianserin by mouse and human hepatic microsomes.
  • The influence of desipramine and amitriptyline on the accumulation of 3-Hnoradrenaline and its two major metabolites formed from 3-Htyrosine in the rat brain.
  • The effect of nortriptyline-specific active immunization on amitriptyline toxicity and disposition in the rabbit.
  • Evaluation of the Abbott ADx total serum tricyclic immunoassay.
  • The effect of some tricyclic antidepressants on the inhibition of mouse brain monoamine oxidase in-vivo by phenelzine.
  • Chronic injections of saline produce subsensitivity to nicotine.
  • Sodium-independent transport of noradrenaline in mouse and rat astrocytes in primary culture.
  • Effects of triiodothyronine (T3) on the potentiation by antidepressants of L-5-hydroxytryptophan-induced head-twitches in mice.
  • Inhibition of 22Na influx by tricyclic and tetracyclic antidepressants and binding of 3Himipramine in bovine adrenal medullary cells.
  • Inhibition of desmethylimipramine 2-hydroxylation by drugs in human liver microsomes.
  • In vitro and ex vivo effects of antidepressants on rat brain membrane-bound phosphatidylinositol synthetase activity.
  • Influence of neuroleptics on the metabolism of tricyclic antidepressants--in vitro experiments with rat liver microsomes.
  • Lipid solubility of a series of drugs and its relevance to fatal poisoning.
  • Effects of various tricyclic antidepressants on amine uptake.
  • Further observations on the effects of the treatment with amitriptyline and perphenazine in essential headache
  • Cytochrome P-450 cholesterol 7 alpha-hydroxylase: inhibition of enzyme deactivation by structurally diverse calmodulin antagonists and phosphatase inhibitors.
  • Failure of chlorpromazine or amitriptyline ointments to influence the course of experimental cutaneous leishmaniasis.
  • PLACE OF AMITRIPTYLINE AMONG THE ANTIDEPRESSIVE AGENTS
  • Plasma amitriptyline levels and its therapeutic effect in endogenous depression
  • Prediction of the effect of antidepressants in patients with endogenous depression
  • Effects of amitriptyline, desipramine and mianserin on noradrenergic transmission in the rat isolated right ventricle.
  • Anticonvulsant drugs and the genetically epilepsy-prone rat.
  • Measurement of basal plasma levels of 3 anterior pituitary hormones during acute or chronic treatment with tricyclic antidepressants
  • Epileptic fits as a probable side-effect of amitriptyline. Report of seven cases.
  • Vasculitis in amitriptyline therapy
  • A comparison of doxepin with diazepam and amitriptyline in general practice.
  • Propranolol in the treatment of cardiac arrhythmias associated with amitriptyline intoxication.
  • Amitriptyline, diazepam, and phenobarbital sodium in depressed outpatients.
  • Clinical experiences with amitriptyline on depressive states
  • Letter: Antiasthmatic effect of amitriptyline.
  • Comparison of desipramine, amitriptyline, zimeldine and alaproclate in six animal models used to investigate antidepressant drugs.
  • Gas chromatographic determination of amitriptyline, nortriptyline and perphenazine in plasma of schizophrenic patients after administration of the combination of amitriptyline with perphenazine.
  • The effects of physostigmine on amitriptyline induced cardiotoxicity in dogs.
  • Amitriptyline, Differential activity of tricyclic antidepressive agents
  • Determination of therapeutic and toxic concentrations of doxepin and loxapine using gas-liquid chromatography with a nitrogen-sensitive detector, and gas chromatography-mass spectrometry of loxapine.
  • Tricyclic antidepressants in serum by a Clin-ElutTM column extraction and high pressure liquid chromatographic analysis.
  • Further contribution to the knowledge of acute accidental poisoning with amitriptyline in children. (Apropos of 2 cases, including 1 fatal case)
  • Hemo-respiratory effects of a thymo-analeptic (amitriptyline) in the healthy subject
  • Amitriptyline + perphenazine in depressive illness--a preliminary report.
  • Correlations between serum ami- and nortriptyline concentrations and psychomotor performance.
  • Some pharmacological aspects of desmethylclomipramine.
  • Electrophysiological effects of antidepressants on mammalian hearts and crayfish giant axon.
  • Quantitative GLC determination of cis- and trans-isomers of doxepin and desmethyldoxepin.
  • The effect of zimelidine and amitriptyline on the brain concentration of some indolic and phenolic monoamines in the mouse.
  • Membrane action of tricyclic drugs. Spectroscopic studies of a series of phenothiazines compared with tricyclic antidepressive substances in red cell membrane, using the spin labelling technique.
  • Cardiovascular, sedative and anticholinergic effects of amitriptyline and zimelidine in young and elderly volunteers.
  • Serum levels and response to amitriptyline in depressed out-patients.
  • Antiarrhythmic activity of amitriptyline analogues in conscious dogs after myocardial infarction: cyproheptadinium methiodide.
  • Prolactin and growth hormone response to levodopa in affective illness.
  • Studies on the participation of the dopaminergic system in the central effects of chronically administered antidepressant drugs.
  • Simultaneous evaluation by a double labelling method of drug-induced uptake inhibition and release of dopamine in synaptosomal preparation of rat striatum.
  • Chronic depression: response to amitriptyline after discontinuation.
  • The methylphenidate test for differentiating desipramine-responsive from nortriptyline-responsive depression.
  • Liquid-chromatographic determination of eight tri- and tetracyclic antidepressants and their major active metabolites.
  • Formation of volatile carcinogenic N-nitroso compounds from drugs under simulated human gastric conditions
  • Depression, antidepressants, and plasma DBH.
  • Plasma binding variations of amitriptyline and nortriptyline.
  • Significance of lipoproteins in serum binding variations of amitriptyline, nortriptyline, and quinidine.
  • Gas chromatographic analysis of therapeutic concentrations of maprotiline in serum, using flame-ionization detection.
  • Imine analogues of tricyclic antidepressants.
  • Tricyclic antidepressants: a simplified approach for the routine clinical monitoring of parent drug and metabolites in plasma using HPLC.
  • NMR spectral study of proton transfer in amitriptyline hydrochloride--chlordiazepoxide hydrochloride combinations in dipolar aprotic solvent.
  • Amitriptyline, nortriptyline plasma levels and clinical response in women with affective disorders.
  • Effect of some psychotropic drugs on spontaneous electromyographic activity in the stressed rat
  • Effects of psychopharmacologic therapy on heart rate variation
  • Protective action of diazepam and of sympathomimetic amines against amitryptyline-induced toxicity.
  • Effects of different types of stress on histamine-H3 receptors in the rat cortex.
  • Chronic pain in the spinal cord injured: statistical approach and pharmacological treatment.
  • Mechanisms of ventricular arrhythmia during amitriptyline toxicity.
  • Studies on antidepressant action of a new oxazolidinone derivative AS-8.
  • Potentiation of clonidine analgesia by amitriptyline.
  • Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content.
  • Male sexual side effects associated with antidepressants: a descriptive clinical study of 32 patients.
  • Effect of neuropeptide FMRFamide on immobile behavior in rats.
  • Sympatholytic effect of tricyclic antidepressants: site and mechanism of action in anesthetized rats.
  • Enhancement of cyclic AMP accumulation mediated by 5-HT after chronic amitriptyline treatment in NG 108-15 cells.
  • Pharmacotherapy of mental disorders with a combination of amitriptyline and perphenazine
  • Antidepressant therapy. A possible cause of atypical cutaneous lymphoid hyperplasia.
  • Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats.
  • State of the blood circulation system in acute poisoning in young children
  • Dopamine D2 receptors: a potential pharmacological target for nomifensine and tranylcypromine but not other antidepressant treatments.
  • Antidepressants and suicide.
  • 5-HT6 receptors positively coupled to adenylyl cyclase in striatal neurones in culture.
  • Frequency-dependent effects of amitriptyline and maprotiline on conduction in the guinea pig His-Purkinje-system in vivo.
  • Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders.
  • The relationship between the pharmacological effect of amitriptyline based on an improved forced-swimming test and plasma concentration in rats.
  • Undesirable effects of drugs. Epidemiologic study at a psychiatric service of a university hospital
  • TREATMENT OF MENTAL DISORDERS IN DECOMPENSATED COR PULMONALE WITH AMITRIPTYLINE
  • Inhibitory effects of antidepressants on NMDA-induced currents in Xenopus oocytes injected with rat brain RNA.
  • Interaction of chlorpromazine with tricyclic anti-depressants in schizophrenic patients.
  • Participation of opioid and monoaminergic mechanisms on the antinociceptive effect induced by tricyclic antidepressants in two behavioural pain tests in mice.
  • Amitriptyline facilitates the analgesic effect of adrenal medulla autograft in the lumbar subarachnoid space of the rat
  • Relative mortality from overdose of antidepressants.
  • Detection of antidepressant and antipsychotic drugs in postmortem human scalp hair.
  • Effects of imipramine and amitriptyline on intraventricular conduction, effective refractory period, incidence of ventricular arrhythmias induced by programmed stimulation, and on electrocardiogram after myocardial infarction in dog.
  • Greater toxicity in overdose of dothiepin than of other tricyclic antidepressants.
  • The relationship between properties of antipsychotic drugs and cataract formation.
  • Effects of des-Tyr-D-Phe3beta-casomorphin (2-5) on cortical EEG power spectra in rats.
  • Facilitated shock-induced aggression after chronic treatment with antidepressant drugs in the rat.
  • Effects of epinephrine, norepinephrine, magnesium sulfate, and milrinone on survival and the occurrence of arrhythmias in amitriptyline poisoning in the rat.
  • Tricyclic antidepressants inhibit opioid receptor binding in human brain and hepatic morphine glucuronidation.
  • Depressive states in old age and their therapy--1983-1993 survey
  • Medicine self-poisoning and the sources of the drugs in Lund, Sweden.
  • Evaluation of the antipyretic action of psychotropic drugs and their effect on the antipyretic effect of acupuncture therapy
  • Brain 5-HT1C receptors and antidepressants.
  • Deaths from substance overdose in the Lothian and Borders region of Scotland (1983-1991).
  • Effect of amitriptyline on neurotransmitter levels in adult mice following infection with the avirulent strain of Semliki Forest virus.
  • Site- and test-dependent antinociceptive efficacy of amitriptyline in rats.
  • Tranylcypromine does not enhance the effects of amitriptyline on 5-HT2 receptors in rat cerebral cortex.
  • Amitriptyline produces dose-dependent supersensitivity of a central cholinergic mechanism.
  • Comparative effects of fluoxetine, amitriptyline and serotonin on functional motor recovery after sensorimotor cortex injury.
  • The effect of repeated combined treatment with nifedipine and antidepressant drugs or electroconvulsive shock on the hippocampal corticosteroid receptors in rats.
  • Effect of chlorpromazine and amitriptyline on the level of acetylcholine in the brain
  • Pharmacists' use of safety caps on refilled prescriptions.
  • A comparison of weight changes with fluoxetine, desipramine, and amitriptyline: a retrospective study of psychiatric inpatients.
  • Concurrent liquid chromatographic measurement of fluoxetine, amitriptyline, imipramine, and their active metabolites norfluoxetine, nortriptyline, and desipramine in plasma.
  • Cardiovascular effects of amitriptyline in therapeutic dosages. Echocardiographic study
  • The effect of long-term treatment with antidepressant drugs on the hippocampal mineralocorticoid and glucocorticoid receptors in rats.
  • Modification of tricyclic antidepressant analgesia by calcium channel blockers.
  • Anti-hypoxic and anti-ischemic actions of indeloxazine hydrochloride and its optical isomers: possible involvement of cerebral energy metabolism.
  • Effects of amitriptyline on depressive and anxiety states in penitentiary inmates.
  • Pharmacology of 9-gamma-methylaminopropyl-9,10-dihydro-9,10-methanoanthracene-HCl (ID-9206-HCl), a new potent antidepressant.
  • Tricyclic antidepressants block NMDA receptor-mediated synaptic responses and induction of long-term potentiation in rat hippocampal slices.
  • Drug analysis in fly larvae.
  • Work loss and depression. Impact of fluoxetine
  • The influence of amitriptyline and flunarizine on catecholamine response to light in patients with migraine.
  • Determination of tricyclic antidepressants in human plasma by micellar electrokinetic capillary chromatography.
  • Amitriptyline inhibits neurite outgrowth in chick cerebral neurons: a possible mechanism.
  • Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.
  • The effects of single and repeated administration of MAO inhibitors on acoustic startle response in rats.
  • Ca2+ release from inositol 1,4,5-trisphosphate-sensitive Ca2+ store by antidepressant drugs in cultured neurons of rat frontal cortex.
  • 5-HT1A receptor function in depression: effect of chronic amitriptyline treatment.
  • Minor and clinically non-significant interaction between toloxatone and amitriptyline.
  • A comparison of the regulatory properties of striatal and cortical adenylate cyclase.
  • Evidence for a role of 5-HT1C receptors in the antiserotonergic properties of some antidepressant drugs.
  • Expression analysis of the mixed function oxidase system in rat brain by the polymerase chain reaction.
  • Diabetic thoracoabdominal neuropathy. Clinical and electrophysiological study with evaluation of the autonomic nervous system
  • The use of phenothiazines and tricyclic antidepressants in the treatment of intractable pain.
  • Effect of amitriptyline on blood glucose level in rabbits.
  • Releases of norepinephrine and dopamine in ventriculocisternal perfusions in hepatectomized and laparotomized rats.
  • Effect of repeated amitriptyline administration to mice on the T lymphocyte proliferative activity and natural killer cell cytotoxicity.
  • The effects of antidepressant drugs on salivary flow and content of sodium and potassium ions in human parotid saliva.
  • A thin-layer method for the determination of amitriptyline and nortriptyline in plasma.
  • Effects of divalproex sodium on amitriptyline and nortriptyline pharmacokinetics.
  • The toxicological characteristics of the interaction of cholinolytics with aminostigmine--a new reversible cholinesterase inhibitor
  • Stereoselective reversible ketone formation from 10-hydroxylated nortriptyline metabolites in human liver.
  • Reflexes of the cutaneous microcirculation in amitriptyline and in fluoxetine treated patients.
  • Fluoxetine and tricyclic antidepressants: clinical tolerance in short-term combined administration
  • The effectiveness of chiropractic manipulation in the treatment of headache: an exploration in the literature.
  • D1 receptor binding in rat striatum: modification by various D1 and D2 antagonists, but not by sibutramine hydrochloride, antidepressants or treatments which enhance central dopaminergic function.
  • Signal-averaged ECG in patients with antidepressant therapy.
  • Antidepressant drugs given repeatedly change the binding of the dopamine D2 receptor agonist, 3HN-0437, to dopamine D2 receptors in the rat brain.
  • Effect of antidepressants on ATP content, 3H-valine incorporation and cell morphometry of astrocytes cultured from rat brain.
  • A new type of treatment of depression with a combination of amitriptyline and protriptyline in clinical psychiatry
  • Postmortem diffusion of drugs from gastric residue: an experimental study.
  • Phenothiazines are potent inhibitors of osteoclastic bone resorption.
  • Praziquantel impairs the ability of exogenous serotonin to stimulate carbohydrate metabolism in intact Schistosoma mansoni.
  • Additive effects of glyburide and antidepressants in the forced swimming test: evidence for the involvement of potassium channel blockade.
  • Can the effects of antidepressants be observed in the first two weeks of treatment?
  • Differential effects of antiarrhythmic agents on post-pause repolarization in cardiac Purkinje fibres.
  • Simultaneous determination of amitriptyline, nortriptyline and four hydroxylated metabolites in serum by capillary gas-liquid chromatography with nitrogen-phosphorus-selective detection.
  • Voltammetric determination of imipramine hydrochloride and amitriptyline hydrochloride using a polymer-modified carbon paste electrode.
  • Chronic antidepressant exposure enhances 5-hydroxytryptamine7 receptor-mediated cyclic adenosine monophosphate accumulation in rat frontocortical astrocytes.
  • The effect of the potassium channel activator, cromakalim, on antidepressant drugs in the forced swimming test in mice.
  • Pharmacological studies of drug action on CNS, with special reference to effects of maprotiline.
  • Phenytoin prophylaxis of cardiotoxicity in experimental amitriptyline poisoning.
  • Cooperativity in oxidations catalyzed by cytochrome P450 3A4.
  • Evaluation of a colloidal metal immunoassay device for the detection of tricyclic antidepressants in urine.
  • Therapeutic drug monitoring databases for postmarketing surveillance of drug-drug interactions: evaluation of a paired approach for psychotropic medication.
  • Metabolism of amitriptyline with CYP2D6 expressed in a human cell line.
  • Structural and concentration effects on the deposition of tricyclic antidepressants in human hair.
  • Norepinephrine, clonidine, and tricyclic antidepressants selectively stimulate carbohydrate ingestion through noradrenergic system of the paraventricular nucleus.
  • Influence of antidepressant drugs on learning and memory paradigms in mice.
  • The effects of different monoaminergic antidepressants on the analgesia induced by spinal cord adrenal medullary transplants in the formalin test in rats.
  • Cytochromes P450 mediating the N-demethylation of amitriptyline.
  • Different effects of inhibitors on the O- and N-demethylation of codeine in human liver microsomes.
  • Pharmacological studies on drugs acting on the social behaviour of the squirrel monkey. Effects of amineptine, piribedil, d-amphetamine, and amitriptyline.
  • Selective determination of amitriptyline and nortriptyline in human plasma by HPLC with ultraviolet and particle beam mass spectrometry.
  • Effects of amitriptyline on the contractile function of the myocardium. Dobutrex in the role of a positive inotropic agent
  • Investigation of pharmacokinetics and of possible adverse effects in infants exposed to tricyclic antidepressants in breast-milk.
  • Pharmacological studies on YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT2A receptor antagonistic activity.
  • Central poststroke pain and Wallenberg's lateral medullary infarction: frequency, character, and determinants in 63 patients.
  • The utilization of antidepressants--a key issue in the prevention of suicide: an analysis of 5281 suicides in Sweden during the period 1992-1994.
  • Inhibitory effect of amitriptyline on contraction of the rat isolated trachea.
  • Effects of tricyclic and tetracyclic antidepressants on the three subtypes of GABA transporter.
  • Does Ca2+ channel blockade modulate the antidepressant-induced changes in mechanisms of adrenergic transduction?
  • Selective deficiency of debrisoquine 4-hydroxylase activity in mouse liver microsomes.
  • Effect of antidepressant drugs and different receptor antagonists on the grooming induced by the dopamine D-1 agonist SKF 38393.
  • Use of antidepressants by nonpsychiatrists in the treatment of medically ill hospitalized depressed elderly patients.
  • Effect of antidepressant therapy on health care utilization and costs in primary care.
  • Examination of metabolic pathways and identification of human liver cytochrome P450 isozymes responsible for the metabolism of barnidipine, a calcium channel blocker.
  • Seizures and myoclonus associated with antidepressant treatment: assessment of potential risk factors, including CYP2D6 and CYP2C19 polymorphisms, and treatment with CYP2D6 inhibitors.
  • Inhibition of skin protein kinase C by psychotropic drugs.
  • Utilization patterns of tricyclic antidepressants in a multidisciplinary pain clinic: a survey.
  • Interactions between promazine and antidepressants at the level of cellular distribution.
  • Prevention of amitriptyline-induced avoidance impairment by tacrine in mice.
  • A comparison of high-performance liquid chromatography and fluorescence polarization immunoassay for therapeutic drug monitoring of tricyclic antidepressants.
  • Scalp dysesthesia.
  • Amitriptyline and alcohol--a commentary
  • Postmortem amitriptyline pharmacokinetics in pigs after oral and intravenous routes of administration.
  • Time-dependent effects of antidepressant drugs on the low dose of apomorphine-induced locomotor hypoactivity in rats.
  • Haloperidol-induced catalepsy: a model for screening antidepressants effective in treatment of depression with Parkinson's disease.
  • Antidepressant-like effects of endogenous histamine and of two histamine H1 receptor agonists in the mouse forced swim test.
  • Differential effects of chronic administration of the antidepressants amitriptyline and rolipram on adenylyl cyclase activity.
  • Quantitative determination of tricyclic antidepressants and their metabolites in plasma by solid-phase extraction (Bond-Elut TCA) and separation by capillary gas chromatography with nitrogen-phosphorous detection.
  • Amitriptyline is effective in chronic but not in episodic tension-type headache: pathogenetic implications.
  • The involvement of the opioidergic system in the antinociceptive mechanism of action of antidepressant compounds.
  • Effects of antidepressant drugs on rats bred for low activity in the swim test.
  • The 5-hydroxytryptamine6 receptor-selective radioligand 3HRo 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum.
  • Effects of psychotropic drugs on thermal responses to radiofrequency radiation.
  • Antidepressants and the risk of falls among nursing home residents.
  • Disopyramide, imipramine, and amitriptyline bind to a common site on the transient outward K+ channel.
  • In vitro effect of central nervous system active drugs on the ATPase-ADPase activity and acetylcholinesterase activity from cerebral cortex of adult rats.
  • Antidepressant drugs and heart electrical field.
  • Effect of analgesics on audible and ultrasonic pain-induced vocalization in the rat.
  • Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava).
  • The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain.
  • Stability of tricyclic antidepressants in formalin solutions.
  • Three-dimensional quantitative structure activity relationship analyses of substrates for CYP2B6.
  • The descending cortical control of nociceptive signals: the neurochemical mechanisms and pharmacological control